Asahi Life Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-682
| Closed | -$339K | – | 202 |
|
|
2025
Q1 | $339K | Buy |
+682
| New | +$339K | 0.22% | 123 |
|
|
2024
Q2 | – | Sell |
-795
| Closed | -$462K | – | 214 |
|
|
2024
Q1 | $462K | Sell |
795
-80
| -9% | -$46.5K | 0.28% | 71 |
|
|
2023
Q4 | $464K | Buy |
875
+570
| +187% | +$303K | 0.25% | 59 |
|
|
2023
Q3 | $154K | Sell |
305
-60
| -16% | -$30.4K | 0.05% | 173 |
|
|
2023
Q2 | $190K | Sell |
365
-105
| -22% | -$54.8K | 0.06% | 172 |
|
|
2023
Q1 | $271K | Buy |
470
+20
| +4% | +$11.5K | 0.09% | 161 |
|
|
2022
Q4 | $248K | Hold |
450
| – | – | 0.08% | 176 |
|
|
2022
Q3 | $228K | Sell |
450
-50
| -10% | -$25.3K | 0.07% | 139 |
|
|
2022
Q2 | $272K | Buy |
500
+60
| +14% | +$32.6K | 0.07% | 121 |
|
|
2022
Q1 | $260K | Hold |
440
| – | – | 0.04% | 177 |
|
|
2021
Q4 | $294K | Hold |
440
| – | – | 0.04% | 173 |
|
|
2021
Q3 | $251K | Sell |
440
-720
| -62% | -$411K | 0.03% | 149 |
|
|
2021
Q2 | $585K | Sell |
1,160
-50
| -4% | -$25.2K | 0.08% | 64 |
|
|
2021
Q1 | $552K | Sell |
1,210
-3,281
| -73% | -$1.5M | 0.07% | 78 |
|
|
2020
Q4 | $2.09M | Buy |
4,491
+3,476
| +342% | +$1.62M | 0.27% | 43 |
|
|
2020
Q3 | $448K | Buy |
1,015
+40
| +4% | +$17.7K | 0.07% | 82 |
|
|
2020
Q2 | $353K | Sell |
975
-1,830
| -65% | -$663K | 0.06% | 112 |
|
|
2020
Q1 | $795K | Buy |
2,805
+2,340
| +503% | +$663K | 0.14% | 54 |
|
|
2019
Q4 | $151K | Sell |
465
-800
| -63% | -$260K | 0.02% | 184 |
|
|
2019
Q3 | $368K | Buy |
1,265
+720
| +132% | +$209K | 0.06% | 112 |
|
|
2019
Q2 | $160K | Buy |
+545
| New | +$160K | 0.03% | 191 |
|